Evidence map›Paper›PMID 32145391›Full record

ArticleProtein expression and purification2020

Purification of native CCL7 and its functional interaction with selected chemokine receptors.

Marina V Goncharuk, Debarati Roy, Maxim A Dubinnyi, Kirill D Nadezhdin, Ashish Srivastava, Mithu Baidya, Hemlata Dwivedi-Agnihotri, Alexander S Arseniev, Arun K Shukla

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Atypical chemokine receptors in the immune system.Nature reviews. Immunology · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marina V GoncharukDepartment of Structural Biology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia. Electronic address: m.s.goncharuk@gmail.com.
Debarati RoyDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India.
Maxim A DubinnyiDepartment of Structural Biology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Kirill D NadezhdinDepartment of Structural Biology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Ashish SrivastavaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India.
Mithu BaidyaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India.
Hemlata Dwivedi-AgnihotriDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India.
Alexander S ArsenievDepartment of Structural Biology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Arun K ShuklaDepartment of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, 208016, India. Electronic address: arshukla@iitk.ac.in.
Indian Institute of Technology Kanpur · INInstitute of Bioorganic Chemistry · RU

Funding

DBT-Wellcome Trust India Alliance IA/E/17/1/503687DBT-Wellcome Trust India Alliance IA/I/14/1/501285Wellcome Trust
6 · The paper itself

Abstract

Chemokine receptors form a major sub-family of G protein-coupled receptors (GPCRs) and they are involved in a number of cellular and physiological processes related to our immune response and regulation. A better structural understanding of ligand-binding, activation, signaling and regulation of chemokine receptors is very important to design potentially therapeutic interventions for human disorders arising from aberrant chemokine signaling. One of the key limitations in probing the structural details of chemokine receptors is the availability of large amounts of purified, homogenous and fully functional chemokine ligands, and the commercially available products, are not affordable for in-depth structural studies. Moreover, production of uniformly isotope-labeled chemokines, for example, suitable for NMR-based structural investigation, also remains challenging. Here, we have designed a streamlined approach to express and purify the human chemokine CCL7 as well as its

Indexed as

Chemokine CCL7Receptors, ChemokineHEK293 CellsHumansRecombinant ProteinsCCL7 protein, humanChemokine CCL7Receptors, ChemokineRecombinant ProteinsArrestinsAtypical chemokine receptorsBiased agonismChemokineGPCRG-proteinIsotope labelingNMR spectroscopyRecombinant protein

Identifiers

PMID32145391
PMCPMC7212033
OpenAlexW3011756755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.